Study to Assess the Effect of Macitentan on the Electrocardiogram (ECG) in Healthy Male and Female Subjects

NCT02050802 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Moxifloxacin 400 mg
DRUG: Macitentan 10 mg
DRUG: Macitentan 30 mg
OTHER: Placebo

Sponsor

Actelion